Related Experiment Video
Updated: Feb 25, 2026

Isolation of Papillary and Reticular Fibroblasts from Human Skin by Fluorescence-activated Cell Sorting
Published on: May 7, 2019
Biology of Fibroblast Growth Factor 23: From Physiology to Pathology
Marie Courbebaisse1,2, Beate Lanske1,3
1Division of Bone and Mineral Research OMII, Harvard School of Dental Medicine, Boston, Massachusetts 02115.
Abstract:
Fibroblast growth factor (FGF)23 is a phosphaturic hormone produced by osteocytes and osteoblasts that binds to FGF receptors in the presence of the transmembrane protein αKlotho. FGF23 mainly targets the renal proximal tubule to inhibit calcitriol production and the expression of the sodium/phosphate cotransporters NaPi2a and NaPi2c, thus inhibiting renal phosphate reabsorption. FGF23 also acts on the parathyroid glands to inhibit parathyroid hormone synthesis and secretion. FGF23 regulation involves many systemic and local factors, among them calcitriol, phosphate, and parathyroid hormone. Increased FGF23 is primarily observed in rare acquired or genetic disorders, but chronic kidney disease is associated with a reactional increase in FGF23 to combat hyperphosphatemia. However, high FGF23 levels induce left ventricular hypertrophy (LVH) and are associated with an increased risk of mortality. In this review, we describe FGF23 physiology and the pathological consequences of high or low FGF23 levels.
Insights
Fibroblast growth factor (FGF)23 regulates phosphate and vitamin D metabolism. High FGF23 levels, seen in kidney disease, can cause heart problems and increase mortality risk.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Fibroblast growth factor (FGF)23 is a hormone produced by bone cells.
- FGF23 regulates phosphate and vitamin D metabolism by acting on the kidneys and parathyroid glands.
- Its levels are often elevated in chronic kidney disease (CKD).
Purpose of the Study:
- To review the physiology of FGF23.
- To discuss the pathological consequences of abnormal FGF23 levels.
- To highlight the association between high FGF23 and adverse health outcomes.
Main Methods:
- Literature review of FGF23 physiology and pathology.
- Analysis of FGF23's role in phosphate homeostasis.
- Examination of FGF23's effects on renal and parathyroid function.
Main Results:
- FGF23 inhibits renal phosphate reabsorption and calcitriol production.
- It also suppresses parathyroid hormone (PTH) secretion.
- Elevated FGF23 is linked to left ventricular hypertrophy (LVH) and increased mortality risk.
Conclusions:
- FGF23 plays a critical role in mineral metabolism.
- Dysregulation of FGF23 contributes to cardiovascular complications and mortality.
- Understanding FGF23 is crucial for managing metabolic bone diseases and CKD complications.
Related Concept Videos
Introduction to Fibroblasts
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway

